knowledge -WSS

knowledge

author：Wikipedia 2025-09-06 03:33:00 - browse：429

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Readout Newsletter: Merck, J&J, and long Covid

WSS

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Test for long Covid? Researchers find new clue in blood samples

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Inside the culture of fear in the White House science office of Eric Lander

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Severe heat forecast: Where scorching temperatures will persist over the next week

Wikipedia

knowledge

hotspot

The high cost of giving birth even with insurance

PrEP can help anyone prevent HIV. Why do so few people take it?

Hepatitis C has a cure — but many Americans still lack access to it

Independent physicians launch a new lobbying group

Duchenne breakthrough therapy leaves behind pioneering families

Malaysia cuts short music fest after British band slams anti

Psychedelics group wrestles with new pharma identity

How to protect coverage of PrEP

Wildfire smoke exposes gaps in outdoor worker protections

Francis Collins on trust in science and how Covid communications failed

explore

Readout Newsletter: Merck, J&J, and long Covid

Sophia Smith scores twice for US in in 3

The tragedy of Johnson & Johnson’s Covid vaccine

Test for long Covid? Researchers find new clue in blood samples

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

How to protect coverage of PrEP

entertainment

hotspot

knowledge

explore